UroMems

Otterspace raises $3.7m in pre-seed funding, launches private beta to coordinate internet-native organizations with non-transferable tokens

UroMems

UroMems focuses on designing, developing and commercializing active implantable medical devices. UroMems is highly innovative and focuses on clearly identified clinical unmet needs, not only for their prevalence but also for their negative impact on patient’s quality of life.

LatticeFlow Secures $12 Million to Accelerate Platform to Eliminate AI Data and Model Blind Spots in Computer Vision

Otterspace raises $3.7m in pre-seed funding, launches private beta to coordinate internet-native organizations with non-transferable tokens

Demoboost raises EUR 1.7 million pre-seed to transform how software is bought and sold

Ledgy raises $22 million Series B to fund European expansion

Part 1 | Mastering Product Management Basics: Vision & Roadmap

ottonova defies difficult market conditions, raising EUR 34 million

i2x receives €11 million in funding and appoints second managing director

SumUp raises €590 million and celebrates 10 years of supporting small merchants

TextCortex raises $1.2 million to advance pioneering AI-based writing companion

Lynxcare secures €20 million series A funding round to unlock healthcare data in EU and USA

Get to know UroMems